PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
£130.00
Buy Cerebrolysin in UAE – In Stock & Ready to Ship
Cerebrolysin is a widely researched compound known for its role in neurotrophic and neuroprotective studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing compounds for serious work.
For research use only. Not intended for human or veterinary use.




Cerebrolysin is a peptide-based neurotrophic compound derived from purified porcine brain protein, studied extensively in neuroscience research for its role in neuronal survival, neuroplasticity, neuroprotection, and cognitive function models — giving it one of the most established research profiles of any peptide compound in clinical and pre-clinical neuroscience. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade Cerebrolysin with fast international dispatch and full batch documentation included.
✅ ≥99% Purity — HPLC Verified
✅ Batch-Specific Certificate of Analysis (CoA) Included
✅ Solution Format | GMP Manufactured
✅ Fast International Dispatch to UAE & GCC
Cerebrolysin is a unique neurotrophic preparation composed of low-molecular-weight peptides and amino acids derived from purified porcine brain tissue. Unlike most research peptides which are single synthetic compounds, Cerebrolysin is a complex mixture of biologically active peptide fragments that collectively mimic the activity of naturally occurring neurotrophic factors — including BDNF, NGF, CNTF, and GDNF — without the molecules themselves being large enough to trigger immune responses.
First developed in the 1950s in Austria, Cerebrolysin has accumulated one of the longest and most extensive research histories of any neurotrophic compound, with studies spanning stroke recovery models, neurodegenerative disease research, traumatic brain injury, and cognitive function. Its combination of neurotrophic, neuroprotective, and neuroplasticity-related research properties in a single compound makes it a particularly comprehensive tool for neuroscience laboratories. Research interest from institutions across the UAE and GCC has grown significantly alongside expanding neuroscience programmes in the region.
In controlled laboratory and pre-clinical settings, Cerebrolysin has been studied across a wide range of neurological research applications:
Neurotrophic Factor Mimicry: Cerebrolysin’s peptide fragments are studied for their ability to replicate aspects of BDNF, NGF, and other neurotrophic factor activity — supporting neuronal survival, axonal growth, and synaptic maintenance in neural cell models.
Neuroprotection Research: Studies have examined Cerebrolysin’s effects in models of neuronal injury, oxidative stress, and excitotoxicity — exploring how its peptide components influence neuronal survival under damaging conditions.
Neuroplasticity Studies: Research has used Cerebrolysin to examine synaptic plasticity, dendritic growth, and the formation of new neural connections in cell culture and animal models, making it relevant to studies of learning and memory at the cellular level.
Stroke and Ischaemia Models: Cerebrolysin has been extensively studied in cerebral ischaemia research, examining how neurotrophic support affects neural tissue outcomes in models of blood flow disruption to the brain.
Neurodegenerative Disease Research: Studies have incorporated Cerebrolysin into models examining Alzheimer’s disease pathology, Parkinson’s-related neurodegeneration, and other age-associated neurological conditions at the pre-clinical level.
Traumatic Brain Injury Models: Pre-clinical research has examined Cerebrolysin’s behaviour in TBI models, looking at its influence on inflammatory markers, neuronal survival, and functional recovery parameters.
Cognitive Function Research: Animal model studies have used Cerebrolysin to examine learning, spatial memory, and cognitive performance parameters, contributing to a broader understanding of how neurotrophic support influences cognition at the cellular level.
All applications listed are research-based only. Cerebrolysin as supplied is for laboratory research use only.
Cerebrolysin has one of the most extensive research profiles of any neurotrophic compound in pre-clinical and clinical neuroscience:
Decades of pre-clinical research have documented Cerebrolysin’s neurotrophic and neuroprotective properties across multiple neural tissue models, with studies consistently reporting its influence on neuronal survival markers, synaptic density, and neurotrophic factor expression in cell culture and animal settings. Stroke research has produced a substantial body of work examining Cerebrolysin in ischaemia models, with pre-clinical studies reporting reductions in infarct-associated markers and improvements in neurological outcome parameters in animal studies. Alzheimer’s disease research has incorporated Cerebrolysin into models examining amyloid pathology and tau protein dysregulation, with studies exploring how neurotrophic support interacts with neurodegeneration mechanisms. Traumatic brain injury research has examined Cerebrolysin’s effects on post-injury neuroinflammation and neural repair processes in pre-clinical models. Its multi-component neurotrophic profile — engaging multiple growth factor pathways simultaneously through its diverse peptide fraction — has been highlighted as a key distinguishing feature compared to single-target neurotrophic compounds, making it a valuable research tool for laboratories studying complex neurological processes across multiple pathways simultaneously.
| Feature | Cerebrolysin | P21 | Semax |
|---|---|---|---|
| Origin | Porcine brain peptides | Synthetic CNTF-derived | Synthetic ACTH-derived |
| Primary Focus | Broad neurotrophic support | BDNF pathway / SOCS2 | Cognitive & neuroprotection |
| Neurotrophic Factors Mimicked | BDNF, NGF, CNTF, GDNF | BDNF focused | BDNF influenced |
| Research History | Extensive (60+ years) | Emerging | Moderate |
| Format | Solution | Lyophilised powder | Lyophilised powder |
| Parameter | Specification |
|---|---|
| Origin | Purified porcine brain protein fractions |
| Composition | Low-MW peptides and free amino acids |
| Neurotrophic Profile | BDNF, NGF, CNTF, GDNF mimetic activity |
| Purity | ≥99% (HPLC Verified) |
| Format | Solution |
| Storage | 2–8°C, protect from light and freezing |
| Shelf Life | As indicated on batch documentation |
Every order of Cerebrolysin dispatched to the UAE and GCC includes:
Can I buy Cerebrolysin in the UAE? Yes. We supply research-grade Cerebrolysin with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged with temperature-considerate handling to maintain compound integrity throughout transit.
What makes Cerebrolysin different from single peptide neurotrophic compounds?
Unlike single synthetic peptides such as P21 or Semax which target specific pathways, Cerebrolysin is a complex mixture of low-molecular-weight peptide fractions that collectively engage multiple neurotrophic factor pathways simultaneously — mimicking aspects of BDNF, NGF, CNTF, and GDNF activity in one compound. This multi-pathway profile makes it a comprehensive research tool for laboratories studying complex neurological processes that involve more than one neurotrophic signalling system.
Why does Cerebrolysin have such an extensive research history?
Cerebrolysin was first developed in the 1950s and has since been studied across an unusually wide range of neurological research contexts — from stroke and TBI models to neurodegenerative disease and cognitive research. Its longevity as a research compound reflects both its broad neurotrophic activity and its consistent pre-clinical profile across multiple study types, which has sustained research interest across successive generations of neuroscience investigation.
How should Cerebrolysin be stored?
Cerebrolysin solution should be stored at 2–8°C, protected from light and away from freezing temperatures. Unlike lyophilised peptides, Cerebrolysin should not be frozen as this can affect the integrity of its peptide fractions. Always follow the storage instructions provided with your batch documentation.
What purity standard is used for Cerebrolysin?
Our Cerebrolysin is verified to ≥99% with full certificates of analysis provided per batch, including HPLC chromatogram and mass spectrometry confirmation of the peptide fraction profile.
How quickly is Cerebrolysin delivered to UAE?
Orders are dispatched promptly via tracked international courier with appropriate cold-chain packaging. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain solution stability throughout transit.
Research Disclaimer: Cerebrolysin is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. Handling should only be performed by qualified laboratory professionals in controlled research settings. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.




WhatsApp us
Receive News